WSTNYQHealthcare·Medical Instruments & Supplies#6 in industry

West Pharmaceutical Services, Inc.

Reports in 87d· 2026-07-23

+25.3% · 90d

$301.40

-4.77 (-1.56%)

News

(1)

April 2026

Apr 23, 20264 days ago8-KHealthcare

WST Raises 2026 Guidance After Strong Q1 Earnings

WSTWEST PHARMACEUTICAL SERVICES INC

# 🧾 What This Document Is This is an 8-K filing, specifically a **current report** that companies use to announce major events to investors. Attached to it is Exhibit 99.1, which is West Pharmaceutical's official **press release for their first-quarter 2026 earnings**. It's their report card for th

Read summaryView on SEC EDGAR

Key Data

Market Cap$21.29B

Open$304.40

Prev Close$306.16

Day Range$300.44 – $309.54

52W Range$202.79 – $322.34

Volume555,203

P/E (TTM)40.35

EPS$7.47

Dividend Yield0.29%

Beta1.15

Profit Margin16.85%

Revenue Growth21.00%

Price Target$349.85(+16.1%)

Next Earnings2026-07-23(87d)

Analyst Ratings

Strong Buy15 analysts

Buy 12Hold 3Sell 0

About

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Healthcare · Medical Instruments & Supplies

10,800 employees

www.westpharma.com